Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin and enamel are the primary mineralized tissues that constitute the human tooth. Enamel is the hardest substance in the human body, consisting of approximately 96% inorganic material (primarily hydroxyapatite) and 4% organic material and water (StatPearls, Histology, Enamel). It forms the outer protective layer of the tooth crown and is acellular, meaning it cannot regenerate once damaged. Dentin lies beneath the enamel and cementum, forming the bulk of the tooth structure; it is a living tissue containing microscopic channels called dentinal tubules (StatPearls, Histology, Dentin). Dentin is composed of roughly 70% hydroxyapatite, 20% organic material (mostly type I collagen), and 10% water. While not traditional molecular receptors, these tissues are the therapeutic focus for remineralizing agents like fluoride, which converts hydroxyapatite into the more acid-resistant fluorapatite to prevent dental caries (NIH, Fluoride in Caries Prevention). Additionally, treatments for dentin hypersensitivity aim to occlude the dentinal tubules or desensitize the nerve endings within the pulp-dentin complex (Journal of Conservative Dentistry, Dentin Hypersensitivity). Pathological degradation of these tissues leads to conditions like dental caries and hypersensitivity, making their structural integrity a focal point of oral health interventions.
Remineralization of hydroxyapatite through the formation of fluorapatite; occlusion of dentinal tubules to reduce sensitivity; inhibition of bacterial metabolism; stabilization of the mineral-collagen matrix.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dental Enamel and Dentin.